Cargando…
Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
BACKGROUND: Pap cytology is known to be more specific but less sensitive than testing for human papillomavirus (HPV) for the detection of high-grade cervical intraepithelial neoplasia (CIN2+). We assessed whether p16/Ki-67 dual-stained cytology, a biomarker combination indicative of transforming HPV...
Autores principales: | Ikenberg, Hans, Bergeron, Christine, Schmidt, Dietmar, Griesser, Henrik, Alameda, Francisco, Angeloni, Claudio, Bogers, Johannes, Dachez, Roger, Denton, Karin, Hariri, Jalil, Keller, Thomas, von Knebel Doeberitz, Magnus, Neumann, Heinrich H., Puig-Tintore, Luis M., Sideri, Mario, Rehm, Susanne, Ridder, Ruediger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814411/ https://www.ncbi.nlm.nih.gov/pubmed/24096620 http://dx.doi.org/10.1093/jnci/djt235 |
Ejemplares similares
-
p16(INK4a)/Ki-67 dual stain cytology for cervical cancer screening in Thika district, Kenya
por: Ngugi, Caroline Wangari, et al.
Publicado: (2015) -
Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021) -
Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki‐67 dual‐stained cytology—Retrospective insights from ATHENA
por: Stoler, Mark H., et al.
Publicado: (2019) -
Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16(INK4a)/Ki-67 dual stain cytology in Western Kenya
por: Orang’o, Elkanah Omenge, et al.
Publicado: (2020) -
Application of p16/Ki-67 dual-staining cytology in cervical cancers
por: Yu, Li, et al.
Publicado: (2019)